Navigation Links
Vermillion Reports First Quarter 2013 Results
Date:5/15/2013

sands, Except Share and Per Share Amounts)(Unaudited)Three Months Ended March 31, 20132012Revenue:Product

$
214$
98License

114114Total revenue

328312Cost of revenue:Product

3738Total cost of revenue

3738Gross profit

291274Operating expenses:Research and development(1)

484452Sales and marketing(2)

1,0721,518General and administrative(3)

1,337468Total operating expenses

2,8932,438Loss from operations

(2,602)(2,164)Interest income

28Interest expense

-(65)Gain on litigation settlement, net

-379Reorganization items

-88Other income (expense), net

29(22)Loss before income taxes

(2,571)(1,776)Income tax benefit (expense)

--Net loss

$
(2,571)$
(1,776)Net loss per share - basic and diluted

$
(0.17)$
(0.12)Weighted average common shares used to compute basic and diluted net loss per common share

15,201,61614,903,455Net loss

(2,571)(1,776)Foreign currency translation adjustment

-(3)Comprehensive loss

$
(2,571)$
(1,779)Non-cash stock-based compensation expense included in operating expenses:(1)  Research and development

$
20$
34(2)  Sales and marketing

5436(3)  General and administrative

10770 


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vermillion Sharpens Focus and Streamlines Operations in 2012
2. Vermillion Reports Fourth Quarter and Full Year 2011 Results
3. Vermillion Reports First Quarter 2012 Results
4. Concerned Stockholders Launch Save Vermillion! Website: www.savevrml.com
5. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
6. Vermillion to Report Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013
7. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
8. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
9. Interleukin Genetics Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
11. Nile Therapeutics Reports 2011 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... peer-reviewed publication of original research, reviews and editorials ... and clinical practice, today published a provocative article ... the development, progression and potential treatment of prostate ... endocrinology research and proposes the possibility that there ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... EVANSTON, Ill. , Dec. 19, 2014 ... to develop novel drugs for diseases of the central ... Ph.D., president and chief executive officer, will present at ... Dr. Riedel,s presentation will take place at 3:00 p.m. ... St. Francis in San Francisco, Calif. ...
(Date:12/19/2014)... Dec. 19, 2014 Decision Resources Group finds ... at a 12 percent compound annual growth rate through ... aging population and the increasing adoption of dental implants. ... will also spur demand for dental biomaterials because ... and periodontal treatments. Other key findings from ...
Breaking Biology Technology:Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
... ranking of brand identities. All businesses, whether big or ... corporate identity, images and brand names, mostly via cyber ... domain-name management techniques. , ,For this reason, cyber-image corporations ... other successful operations worldwide do not conjure up the ...
... can raise the seed capital he needs to fuel his ... individuals who are legally allowed to make angel investments. , ... for southeastern Wisconsins tech community, Peter M. Skanavis is doing ... to make angel investments to actually take the plunge and ...
... to help create a technology transfer project in Racine ... , ,The Racine County Economic Development Corporation ... will organize the project, which will license donated ... the Wisconsin Alumni Research Foundation, which handles the legalities ...
Cached Biology Technology:Avoid oblivion by choosing a brand name that dominates 2Avoid oblivion by choosing a brand name that dominates 3Avoid oblivion by choosing a brand name that dominates 4Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 2Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 3Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 4
(Date:12/22/2014)... , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... entertainer and security consultant, Apollo Robbins for ... smart wallet.  Apollo Robbins ... 7 th , 2015, demonstrating some of his famous ...
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research ... announced the addition of the "iPhone 5S ... Technology Report" report to their offering. ... Following the acquisition of AuthenTec in July 2012, ... iPhone 5S. It is currently the only device ...
(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey ... built for the post-password and Internet of Things era, ... seed funding. The venture round was led by Metamorphic ... Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has ... new funding to expand its team and bring LaunchKey ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... and oxygen from water using conventional electrolysis techniques requires ... oxygen from water efficiently using a catalytic technique powered ... photosynthesis and so effective that it is the Earth,s ... artificial systems, this photocatalytic process could provide abundant new ...
... you eat is truism that has been given new impetus by ... your teeth are literally shaped by your food. Indeed, evidence ... by an animal providing a new way of working out the ... looking at the contents of their guts. Scientists say it ...
... Researchers at Virginia Bioinformatics Institute at Virginia Tech ... sequence to aid scientists across the US in a ... for producing biodiesel fuel. The results have been published ... of developing alternative, renewable fuel sources to prevent a ...
Cached Biology News:Scientists study the catalytic reactions used by plants to split oxygen from water 2Scientists study the catalytic reactions used by plants to split oxygen from water 3Incisive research links teeth with diet 2
... Labeling Kit with CyScribe GFX Purification ... and purification of Cy3- and Cy5-labeled ... complete cDNA labeling and purification.Flexible and ... performing labeling reactions with either Cy3- ...
... CyScribe Post-Labeling Kit with CyScribe GFX ... generation and purification of Cy3- and ... for complete cDNA labeling and purification.Flexible ... for performing labeling reactions with either ...
Collected from sexually mature, mixed sex, mixed breed dogs. Serum from specific breeds available by request....
UV-NIR light source for USB2000, HR4000, HR2000+...
Biology Products: